ArticleInternational journal of biological sciences2024

Inhibition of PCSK9 enhances the anti-hepatocellular carcinoma effects of TCR-T cells and anti-PD-1 immunotherapy.

Weikang Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.